HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.

Andere talen Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Aandelen

300255

CNE1000016C2

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
11,55 ^CNY	+2,21%		-2,61%	-11,22%

28/04	Hebei Changshan Biochemical Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
14/03	Yang Minghuan heeft de overname afgerond van 5,8% belang in Hebei Changshan Biochemical Pharmaceutical Co. (SZSE:300255) van Gao Shuhua.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Yang Minghuan completed the acquisition of 5.8% stake in Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from Gao Shuhua.	14/03
Yang Minghuan entered into an agreement to acquire 5.8% stake in Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from Gao Shuhua for CNY 490 million.	24/02
Hebei Changshan Biomedical Pharma's Controlling Shareholder to Sell 5.8% Company Stake	23/02
Changshan Biochemical Pharmaceutical, Unit Get Nod to Trial Tumor Drug	09/01
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24-10-23
Changshan Biochemical Pharmaceutical Gets Nod to Register Deep Vein Thrombosis Drug in Lebanon	19-10-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(XSEC:300255) added to S&P Global BMI Index	18-09-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Changshan Biochemical Pharma Registers Enoxaparin Sodium Injection in Nicaragua	15-06-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022, Payable on June 27, 2023	17-05-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26-04-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	24-04-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21-04-23
Changshan Biochemical Pharma’s Deep Vein Thrombosis Drug Shortlisted For China’s Drug Procurement Program	30-03-23
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(XSEC:300255) dropped from S&P Global BMI Index	19-12-22
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27-10-22
Changshan Biochemical Wins Nod to Register Vein Thrombosis Drug in Turkmenistan	04-10-22
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(XSEC:300255) added to S&P Global BMI Index	19-09-22
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Aandelen

300255

CNE1000016C2

Andere talen

Filters